Genomma Lab Internacional, S.A.B. de C.V.
GNMLF
$1.43
$0.169913.48%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 55.35% | 14.39% | -127.91% | 10.12% | 16.83% |
| Total Depreciation and Amortization | 0.41% | 44.27% | -25.94% | 23.78% | 21.78% |
| Total Amortization of Deferred Charges | -- | -- | 116.45% | -- | -- |
| Total Other Non-Cash Items | 2,666.41% | 197.73% | 69.78% | -46.22% | -133.25% |
| Change in Net Operating Assets | -2,867.66% | -350.98% | 514.71% | 190.03% | 90.17% |
| Cash from Operations | -5.51% | -143.76% | 164.43% | 93.49% | 83.94% |
| Capital Expenditure | 63.76% | 34.90% | 50.36% | 38.27% | 29.45% |
| Sale of Property, Plant, and Equipment | -40.68% | 126.32% | 129.12% | -100.08% | 1,087.36% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -213.65% | -28.55% | -60.91% | 192.06% | 145.43% |
| Cash from Investing | -493.34% | 40.12% | -0.52% | 518.68% | 152.84% |
| Total Debt Issued | -46.31% | 25.00% | -70.89% | 24.00% | 734.49% |
| Total Debt Repaid | 44.67% | 31.30% | 35.92% | 25.06% | -730.07% |
| Issuance of Common Stock | -- | -- | 269.73% | -- | -- |
| Repurchase of Common Stock | -- | -29.73% | -226.07% | -- | 43.39% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -9.89% | -- | 43.87% | -- | 43.88% |
| Other Financing Activities | 1.27% | -6.37% | 62.67% | -4,736.03% | -458.95% |
| Cash from Financing | -5.84% | 11.40% | -373.92% | 45.06% | 23.06% |
| Foreign Exchange rate Adjustments | 164.32% | 87.26% | 275.44% | -62.13% | -14.47% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -43.23% | -124.45% | -138.24% | 327.00% | 153.74% |
